您的位置: 首页 > 农业专利 > 详情页

Lysosomal phospholipase A2 (LPLA2) activity as a therapeutic target for treating systemic lupus erythematosus
专利权人:
James A. Shayman;Akira Abe;Robert Kelly;Ye Lu;Jessica Kollmeyer
发明人:
James A. Shayman,Akira Abe,Robert Kelly,Jessica Kollmeyer,Ye Lu
申请号:
US13272949
公开号:
US09309553B2
申请日:
2011.10.13
申请国别(地区):
US
年份:
2016
代理人:
摘要:
The present invention is directed to methods for diagnosis and treatment of systemic lupus erythematosus and drug-induced systemic lupus erythematosus. More specifically, the specification describes methods using a lysosomal phospholipase A2 in methods for the diagnosis and treatment of autoimmune disorders such as systemic lupus erythematosus and drug-induced systemic lupus erythematosus.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充